Robotics startup Vicarious files pre-submission with FDA, fresh from $425M SPAC raise

Vicarious Surgical has filed a pre-submission with the FDA, marking the start of a regulatory process it hopes will lead to a 510(k) application by late 2023.
The filing, which Vicarious disclosed in its first quarterly results as a public company, is part of a push to establish the robotic surgical system in a space fought over by Intuitive Surgical, Johnson & Johnson and Medtronic.